We found that tumours treated with MEK1‐hi EVs were 61% and 55% smaller in area than tumours treated with vehicle control or with MEK1‐low EVs, respectively (p < 0.05 Figure 3b). The gene discussed is MAP2K1; the disease is neoplasm.